Investor's Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
|
|
|
|
|
|
|
|
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
|
|
|
|
|
|
|
|
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
|
|
|
|
|
|
|
|
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
|
|
|
|
|
|
|
|
|
29
|
30
|
31
|
1
|
2
|
3
|
4
|
|
|
|
|
|
|
|
|
Last News
ROVI reached 201.9 million euros of revenue in the first post-pandemic quarter
3 min
10 May, 2023
The objective of the new three-monthly formulation is to reach bioequivalence in the plasma levels of...
6 min
25 Apr, 2023
The objective is to help improve society’s mental health and take advantage of the opportunities the new...
3 min
12 Apr, 2023
Public statements sent to CNMV
ESG
Discover what ROVI is doing to become a more sustainable company
CORPORATE GOVERNANCE
Find out more about ROVI’s main governing bodies
Information for investors
Marta Campos
Head of Investor Relations
Antonio Marquina
Investor Relations
